Skip to main content
Board meeting minutes

HSE board meeting minutes 29 April 2026

A meeting of the Board of the Health Service Executive was held on Wednesday 29 April 2026 at 9am, via videoconference.

Meeting details

Present

Mr Ciarán Devane (Chairperson), Dr Yvonne Traynor (Deputy Chairperson), Mr Brendan Whelan, Mr Aogán Ó Fearghail, Mr Tim Hynes, Ms Anne Carrigy, Mr Matt Walsh, Mr Michael Cawley, Mr Kenneth Mealy, Ms Lily Collison and Mr Patrick Bailey.

In Attendance for Board Meeting

Ms Anne O’Connor (CEO), Mr Pat Healy, (ND Services and Schemes), Mr Mark Brennock (ND Communications), Mr Tony Canavan (REO West and North West), Ms Sandra Broderick (REO Mid West), Mr Michael Lane (A/CFO), Dr Andy Phillips (REO South East), Ms Martina Queally (REO Dublin & South East), Ms Suzanne Dunne (Regional Director of Planning & Performance), Mr Brian Murphy (Head of Corporate Affairs), Ms Niamh Drew (Deputy Corporate Secretary), Ms Patricia Perry (Office of the Board).

Joined the Meeting

Mr Patrick Lynch (ND Planning & Performance), Mr Brian O’Connell (ND Strategic Health Infrastructure and Capital Delivery), Mr Fran Thompson (CIO), Dr Philippa Ryan Withero (AND HR), Mr Gareth Morton (ND Procurement), Mr Gavin O’Neill (AND National Productivity Unit), Dr Raied Abdul Karim (EHR Programme Director), Ms Martina Burns (EHR Digital Delivery Director), Dr Brendan Murphy (EHR Clinical Lead), Mr Paul Gahan (AND HR)

Minutes reflect the order in which items were considered and are numbered in accordance with the original agenda. All performance/activity data used in this document refers to the latest information available at the time.

1. Board Members Private Discussion

The Chairperson welcomed members to the meeting and provided an update to the Board during their private session.

2. Governance and Administration

The Chairperson welcomed members to the meeting and provided an update to the Board during their private session.

2.1 Declarations of Interest

No conflicts of interest were declared.

2.2 Chairperson’s Remarks

The Chairperson provided an update to the Board on a number of matters that would be discussed during the meeting.

2.3 Ministerial Correspondence

- Letter from Minister for Children, Disability and Equality dated 25 March 2026

2.4 Minutes of Board meeting

The Board approved the minutes of the Board meeting of 25 March 2026.

3. Committees of the Board Briefings

3.1 Audit and Risk Committee

The minutes of Committee meetings of 13 March 2026 were noted. The Committee Chairperson provided an overview to the Board on the matters considered at the Committee meeting that took place on 17 April 2026.

The Board held a discussion on the following areas:

  • A Contract Approval Request was not recommended for Board approval, as the Committee requested further clarification, and will be revisited at the May meeting.
  • The HSE’s approach to Communications and the use of resources including digital and social platforms and responsiveness to negative press.

3.2 Task and Finish Group HSE Financial Position 2026 and Funding Challenges

The minutes of HSE Board Task and Finish Group regarding the 2025 HSE Financial Position of 11 December 2025 were noted. The Group Chairperson provided an overview to the Board on the matters considered at the Committee meeting that took place on 23 April 2026 and advised that the next meeting is scheduled for 22 May 2026.

3.3 Performance Committee

The minutes of Committee meetings of 19 March 2026 were noted. The Committee Chairperson provided an overview to the Board on the matters considered at the Committee meeting that took place on 23 April 2026.

The Board held a discussion on the following areas:

  • The challenges and risks in relation to Home support for Older Persons, difficulties in the recruitment of Healthcare Assistants; and the use of assisted living technologies.
  • The proposed structure to advance the Disability agenda, which is a Government priority.

The Board noted the update provided by a Board member in relation to CHI.

Appointment of External Member

The Chairperson of the Committee requested that the Board approve the appointment of Professor Karina Butler as an external member of the Performance Committee for a term of 3 years until 29 April 2029, which the Board approved. Decision No.: 290426/20

4. Chief Executive Officer

4.1 CEO briefing to the Board

The Board held a detailed discussion with the CEO and A/CFO regarding the YTD financial position. Significant concern was expressed regarding the current level of expenditure in excess of budget and the projected year-end overspend. The Board noted that at end March 2026, the HSE is over budget by €150.7m / 3.2%, (deficit of €145.8m Department of Health (DoH) and €5.0m Department of Children, Disability and Equality (DCDE)).

The CEO advised that, following consideration of the Quarter 1 2026 financial position under the Performance and Accountability Framework (PAF) 2026, three Regional Areas were placed into Tier 3 escalation and the remaining three into Tier 1 escalation with effect from 29 April 2026. The CEO outlined to the Board the escalation requirements and the associated processes in cases where required improvements are not achieved.

The Board discussed governance arrangements, performance oversight, and regional capability. Board members noted the need for greater clarity and consistency in governance structures, alongside stronger central oversight and coordination. It was recognised that the current model has reduced visibility and oversight at the centre, with some regional functions operating with significant autonomy, making it more challenging to maintain a consistent view of performance across the system. The CEO acknowledged these challenges.

Discussion also focused on whether additional senior-level support may be required to strengthen oversight, coordination, and decision-making. Existing reporting arrangements were considered insufficient in providing a clear picture of operational performance and emerging risks, highlighting the need for more robust and actionable information.

Regional performance was described as variable, while regions are broadly operating as intended, concerns were raised about capacity in some areas to manage ongoing financial and operational pressures effectively. Particular challenges were noted in relation to pay and non-pay management, disabilities, mental health, and income generation. It was acknowledged that these pressures are being experienced across the wider system.

The Board considered the significant financial challenges facing the organisation and emphasised the importance of maintaining strong financial discipline while continuing to deliver services in a high-demand environment. Different views were expressed on the balance between regional autonomy and increased central oversight, with agreement that any changes to authority arrangements would require careful consideration.

Board members also highlighted the importance of strengthening performance monitoring through clearer metrics and earlier identification of emerging risks to support timely intervention where needed. There was broad recognition of the sustained pressures facing the system and the seriousness of the current position.

The potential value of targeted reviews and benchmarking exercises was also discussed, including opportunities to learn from previous reviews and assess the effectiveness of specific services and delivery models to support continuous improvement and accountability.

It was agreed that further work would be undertaken to review governance and oversight arrangements, enhance the quality and timeliness of performance reporting, clarify finance roles and responsibilities, and assess regional support requirements. The CEO agreed to revert to the Board in a timely manner with proposals to address the matters raised.

4.2 CEO Monthly Report

Members of the Senior Leadership Team joined the meeting.

The CEO reported to the Board on a number of the key significant areas as set out in the CEO Monthly Report.

The CEO reported to the Board on her first month which focused on establishing key relationships, gaining clarity on the organisation’s principal risks and priorities, and setting clear expectations around performance, financial control, and accountability. The CEO advised the Board that meetings took place with senior leadership, Board members, and Regional Executive Officers and teams, with a particular focus on UEC, financial performance and agency controls. Engagements also took place with the Minister for Health, the newly appointed Secretary General of the DoH, An Taoiseach, Minister for Children, Disability & Equality and other key partner agencies.

The CEO provided an update to Board members in relation to the significant national disruption caused by the fuel protests in early April, noting that the National Crisis Management Team was convened to coordinate the health response, with daily meetings held during the peak of the response and liaising with Departments and Ministers extensively. The CEO and Board acknowledged with thanks the work of all staff, both from a coordination and care delivery perspective, for managing a very challenging situation with minimal impact on patients.

The CEO reported to the Board on Urgent and Emergency Care, outlining significant increased attendances after the Easter holiday period which resulted in higher trolley numbers in some sites. She outlined that analysis has shown that, in part, pressure was driven by an increase in urgent elective activity, notably in haematology and oncology, with OPD admissions increasing 36.4% compared to the previous week.

The Board noted the campaign to appoint a National Director for Disabilities was not successful, and the CEO advised the Board that she is liaising with the A/CPO and Secretary General of DCDE in relation to next steps in relation to the Disabilities Function.

The CEO outlined to the Board the implementation of the revised senior management arrangements with the establishment of the Senior Management Team (SMT) which will focus on decision-making, operational oversight, and performance delivery; and a refocused Senior Leadership Team (SLT) with strengthened responsibility for strategy, assurance, and forward planning; and the Board noted the establishment of a Performance Advisory Group to enhance performance oversight across regions and national services.

The CEO reported to the Board on workforce numbers, noting the WTE increase of 622 between February and March, leaving headroom of 1,270 WTE within the year-to-date ceiling. A material proportion of recruitment relates to Health and Social Care Professions. Active management of the pay bill remains critical to ensure agency overspend does not constrain permanent recruitment.

The Board noted the update in relation to the One Health Record programme with the evaluation of responses to the Requests to Participate underway, and shortlisting for Competitive Dialogue expected in the coming weeks, representing a major programme milestone, and noted further Digital for Care developments outlined in papers presented.

National Performance Report

The monthly National Performance Report (NPR) February 2026 data was presented to the Board.

The Performance Committee also reviewed this at its meeting on 23 April 2026. The Board approved the February 2026 NPR for submission to the Minister for Health, and Department of Children, Disability and Equality (DCDE), and noted that once submitted, the NPR will be published on hse.ie.

5. Reserved Functions

5.1 HSE Annual Report 2025

Board members adopted the HSE Annual Report 2025, and acknowledged the work of the Planning team.

Decision No.: 290426/21

5.2 Contracts & Properties

As recommended by the Audit & Risk Committee for approval, the Board considered and approved the following proposed contracts and properties:

      1. National Hospital Medicine Management System Decision No.: 290426/22
      2. Contract Award for the Construction of a 96 Bed Acute Inpatient Ward Block Development – Phase 2 at University Hospital Limerick Decision No.: 290426/23
      3. Contract award for an extension to the Emergency Department at Mayo University Hospital, including an Acute Medical Assessment Unit Decision No.: 290426/24
      4. Contract award for Passive & Active Fire Safety Works at Midlands Regional Hospital Portlaoise Decision No.: 290426/25
      5. Capital grant to St. Francis Hospice Raheny New In-Patient Unit and Mortuary Decision No.: 290426/26

6. Follow up from Board Strategic Sessions

Further to the Strategic Discussions/Workshops held at the January and March 2026 Board meetings, it was agreed that a programme of work be developed by SLT based on the Board inputs and discussion at the meeting and brought back to the Board.

The Board, CEO and members of the Senior Leadership Team (SLT) held a discussion on three topics:

  • Productivity
  • One Health Record Programme
  • Senior Leadership Development Programme

The Board considered the update in relation to Senior Leadership Development Programme which responded to the Boards feedback from previous meetings, and approved its implementation.

7. Any Other Business and Close

There was no further business. The meeting concluded at 3.20pm

This is a beta version - your feedback will help us to improve it

HSE board meeting minutes 29 April 2026